What are Common Regulatory Challenges in Cancer Treatment?
Common regulatory challenges include: - Stringent Clinical Trial Requirements: Regulatory bodies often require extensive clinical trials to demonstrate the safety and efficacy of new treatments. These trials can be costly and time-consuming. - Complex Approval Processes: Navigating the approval process for new cancer drugs can be complex, requiring detailed documentation and compliance with numerous guidelines. - Post-Marketing Surveillance: Even after approval, cancer treatments are subject to ongoing monitoring for adverse effects and long-term efficacy, which can pose additional regulatory hurdles.